Skip to content

Verification of the Effectiveness of Far-Infrared Blood Circulation-Promoting Garments in Reducing Low Back Pain in Chronic Low Back Pain Cases

A Double-Blind, Parallel-Group, Randomized Controlled Trial on the Effects of Far-Infrared Blood Circulation-Promoting Garments on Trunk Function and Low Back Pain in Individuals with Chronic Nonspecific Low Back Pain - FIBRE-Back trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000060356
Enrollment
56
Registered
2026-01-15
Start date
2026-01-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic low back pain

Interventions

The intervention group wears innerwear with far-infrared blood circulation promotion effects for at least 8 hours daily during daytime hours for 4 weeks. The intervention group performed 10 to 15 min

Sponsors

Morinomiya University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals experiencing low back pain on three or more days per week for three months or longer

Exclusion criteria

Exclusion criteria: Individuals who can touch the floor with their palms during the standing forward bend test, cannot agree to refrain from initiating other pain relief therapies during the trial period, are pregnant or may be pregnant, have recently given birth or are breastfeeding, may exhibit allergic symptoms to the test product material, with skin abnormalities such as wounds, eczema, or irritation in areas where the test product will come into contact, with organic diseases such as herniated discs, experiencing numbness in the hands or feet, with a history of identified structural spinal abnormalities, with acute (painful) conditions such as spinal fractures or muscle strains, who have participated in another clinical trial within the past month or are currently participating in one, with a BMI of 28 or higher, presently receiving prescription medication for internal medical conditions, who cannot consent to the publication of trial footage for promotional purposes in a manner that prevents personal identification (e.g., by obscuring the face), currently receiving outpatient treatment for low back pain.

Design outcomes

Primary

MeasureTime frame
Questionnaire regarding low back pain before intervention and 4 weeks after (Numerical rating scale: NRS, Oswestry disability index: ODI, Pain Catastrophizing Scale: PCS, Pittsburgh Sleep Quality Index: PSQI, and Karolinska Sleepiness Scale: KSS)

Secondary

MeasureTime frame
Spinal alignment and mobility assessment using Spinal Mouse, multifidus muscle thickness assessment using ultrasound imaging equipment, and spinal erector muscle tissue stiffness assessment using MyotonePRO before intervention and 4 weeks after

Countries

Japan

Contacts

Public ContactYoshihiro Maekawa

Morinomiya University of Medical Sciences Department of Medical Technology, Faculty of Medical Science Technology

kenkyu@morinomiya-u.ac.jp06-6616-6911

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026